Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berend Jan Bosch

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Nature Communications|July 29, 2021
A plug-and-play platform of ratiometric bioluminescent sensors for homogeneous immunoassaysYan Ni, Bas J H M Rosier, Eva A van Aalen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoproteinWentao Li, Ruben J G Hulswit, Ivy Widjaja, et al.
The Journal of Infectious Diseases|May 27, 2021
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster ModelBart L Haagmans, Danny Noack, Nisreen M A Okba, et al.
Clinical & Translational Immunology|May 24, 2021
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donorsMaurice Steenhuis, Gerard van Mierlo, Ninotska Il Derksen, et al.
Nature Communications|September 24, 2021
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptomsJaneri Fröberg, Joshua Gillard, Ria Philipsen, et al.
Emerging Infectious Diseases|April 9, 2020
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease PatientsNisreen M A Okba, Marcel A Müller, Wentao Li, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2023
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike proteinVito Thijssen, Daniel L Hurdiss, Oliver J Debski-Antoniak, et al.
Emerging Infectious Diseases|July 22, 2015
Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014Chantal B E M Reusken, Elmoubasher A B A Farag, Bart L Haagmans, et al.
The Lancet. Infectious Diseases|August 13, 2013
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyChantal B E M Reusken, Bart L Haagmans, Marcel A Müller, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|July 29, 2021
A plug-and-play platform of ratiometric bioluminescent sensors for homogeneous immunoassaysYan Ni, Bas J H M Rosier, Eva A van Aalen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoproteinWentao Li, Ruben J G Hulswit, Ivy Widjaja, et al.
The Journal of Infectious Diseases|May 27, 2021
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster ModelBart L Haagmans, Danny Noack, Nisreen M A Okba, et al.
Clinical & Translational Immunology|May 24, 2021
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donorsMaurice Steenhuis, Gerard van Mierlo, Ninotska Il Derksen, et al.
Nature Communications|September 24, 2021
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptomsJaneri Fröberg, Joshua Gillard, Ria Philipsen, et al.
Emerging Infectious Diseases|April 9, 2020
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease PatientsNisreen M A Okba, Marcel A Müller, Wentao Li, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2023
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike proteinVito Thijssen, Daniel L Hurdiss, Oliver J Debski-Antoniak, et al.
Emerging Infectious Diseases|July 22, 2015
Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014Chantal B E M Reusken, Elmoubasher A B A Farag, Bart L Haagmans, et al.
The Lancet. Infectious Diseases|August 13, 2013
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyChantal B E M Reusken, Bart L Haagmans, Marcel A Müller, et al.
Pageof 12